120
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluation

Bevacizumab in the treatment of colorectal cancer

, , &
Pages 739-749 | Published online: 03 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sung Chul Park, Daniel Su & Celso Tello. (2012) Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab. Expert Opinion on Biological Therapy 12:12, pages 1641-1647.
Read now
Guanglin Cui, Yingpeng Shi, Jing Cui, Fuai Tang & Jon Florholmen. (2012) Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?. Scandinavian Journal of Gastroenterology 47:4, pages 367-377.
Read now
Olivia Aranha & Mark Agulnik. (2008) Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions. Expert Opinion on Therapeutic Targets 12:2, pages 197-207.
Read now

Articles from other publishers (18)

Qing Huang, Chunlan Pu, Lun Tan, Shirui Wang, Hongjia Zhang, Su Yu, Rui Deng, Dan Luo, Xinyu Ma & Rui Li. (2022) Synthesis and biological evaluation of a novel c-Myc inhibitor against colorectal cancer via blocking c-Myc/Max heterodimerization and disturbing its DNA binding. European Journal of Medicinal Chemistry 243, pages 114779.
Crossref
Ogugua Ndubuisi Okonkwo, Toyin Akanbi & Chineze Thelma Agweye. 2022. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World.
Tobias P. H. Nissen, Henrik Vorum & Kristian Aasbjerg. (2021) Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema. Current Drug Safety 16:1, pages 17-31.
Crossref
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard & Francesco Bandello. (2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). British Journal of Ophthalmology 98:9, pages 1144-1167.
Crossref
Joan Manel Gasent Blesa & Enrique Grande Pulido. (2010) Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient. Anti-Cancer Drugs 21:Supplement 1, pages S23-S26.
Crossref
Rolf‐P. Ryseck, Ricardo Attar, Matthew V. Lorenzi & Brent A. Rupnow. 2009. Molecular Pathology in Drug Discovery and Development. Molecular Pathology in Drug Discovery and Development 21 45 .
Hossein A. Ghofrani, Robyn J. Barst, Raymond L. Benza, Hunter C. Champion, Karen A. Fagan, Friedrich Grimminger, Marc Humbert, Gérald Simonneau, Duncan J. Stewart, Carlo Ventura & Lewis J. Rubin. (2009) Future Perspectives for the Treatment of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology 54:1, pages S108-S117.
Crossref
Tamara CacevBozo LoncarSven SeiwerthSime SpaventiSanja Kapitanovic. (2008) Vascular Endothelial Growth Factor Polymorphisms −1154 G/A and −460 C/T Are Not Associated with VEGF mRNA Expression and Susceptibility to Sporadic Colon Cancer . DNA and Cell Biology 27:10, pages 569-574.
Crossref
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
John M. Abraham, Yulan Cheng, James P. Hamilton, Bogdan Paun, Zhe Jin, Rachana Agarwal, Takatsugu Kan, Stefan David, Alexandru Olaru, Jian Yang, Tetsuo Ito, Florin M. Selaru, Yuriko Mori & Stephen J. Meltzer. (2008) Generation of Small 32P-Labeled Peptides as a Potential Approach to Colorectal Cancer Therapy. PLoS ONE 3:6, pages e2508.
Crossref
Frank Hilberg, Gerald J. Roth, Martin Krssak, Susanna Kautschitsch, Wolfgang Sommergruber, Ulrike Tontsch-Grunt, Pilar Garin-Chesa, Gerd Bader, Andreas Zoephel, Jens Quant, Armin Heckel & Wolfgang J. Rettig. (2008) BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy. Cancer Research 68:12, pages 4774-4782.
Crossref
Yan Gao, Wei-Xia Zhong, Dian-Bin Mu, Yin-Ping Yuan, Yu-Hua Zhang, Jin-Ming Yu, Lan-Ping Sun, Lei Wang, Yu-Hui Li, Jian-Bo Zhang, Yan Zhao, Shu-Ping Cai & Geng-Yin Zhou. (2008) Distributions of Angiogenesis and Lymphangiogenesis in Gastrointestinal Intramucosal Tumors. Annals of Surgical Oncology 15:4, pages 1117-1123.
Crossref
Alfia Khaibullina, Beom-Su Jang, Haihao Sun, Nhat Le, Sarah Yu, Victor Frenkel, Jorge A. Carrasquillo, Ira Pastan, King C.P. Li & Chang H. Paik. (2008) Pulsed High-Intensity Focused Ultrasound Enhances Uptake of Radiolabeled Monoclonal Antibody to Human Epidermoid Tumor in Nude Mice. Journal of Nuclear Medicine 49:2, pages 295-302.
Crossref
Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, Roxanne Cofiell, Susan J. Faas & Katherine S. Bowdish. (2008) Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy. The Journal of Immunology 180:2, pages 699-705.
Crossref
Maurie Markman. (2008) The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer. Oncology 74:1-2, pages 1-6.
Crossref
Emmanuel Mitry. (2008) A dilemma in geriatric oncology: Malignant bowel obstruction in an 81-year-old man. Cancer Treatment Reviews 34, pages S17-S22.
Crossref
John M. Abraham, Fumiaki Sato, Yulan Cheng, Bogdan Paun, Takatsugu Kan, Alexandru Olaru, Zhe Jin, Jian Yang, Rachana Agarwal, Stefan David, James P. Hamilton, Tetsuo Ito, Yuriko Mori & Stephen J. Meltzer. (2007) Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells. PLoS ONE 2:10, pages e964.
Crossref
Ivan Popov, Dino Tarabar, Dusan Jovanovic, Vladimir Kovcin, Stojan Radic, Marjan Micev, Zoran Petrovic, Nebojsa Manojlovic, Zoran Andric, Aleksandar Dagovic, Biljana Kukic, Ljiljana Radosevic-Jelic, Dragutin Kecmanovic, Jeremija Josifovski & Svetla Jezdic. (2007) Efficacy and safety of bevacizumab in combination with oxaliplatin, irinotecan and fluoropyrimidine-based therapy in advanced colorectal cancer. Archive of oncology 15:1-2, pages 10-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.